Zsuzsa Bagoly

2.2k total citations
64 papers, 1.6k citations indexed

About

Zsuzsa Bagoly is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Zsuzsa Bagoly has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 27 papers in Pulmonary and Respiratory Medicine and 19 papers in Epidemiology. Recurrent topics in Zsuzsa Bagoly's work include Blood properties and coagulation (26 papers), Acute Ischemic Stroke Management (17 papers) and Venous Thromboembolism Diagnosis and Management (14 papers). Zsuzsa Bagoly is often cited by papers focused on Blood properties and coagulation (26 papers), Acute Ischemic Stroke Management (17 papers) and Venous Thromboembolism Diagnosis and Management (14 papers). Zsuzsa Bagoly collaborates with scholars based in Hungary, United States and Poland. Zsuzsa Bagoly's co-authors include László Muszbek, Ëva Katona, István Komáromi, Zsuzsanna Bereczky, László Csiba, Jolán Hársfalvi, Zsuzsa Koncz, István Szegedi, Gizella Haramura and Amir H. Shemirani and has published in prestigious journals such as Physiological Reviews, Blood and PLoS ONE.

In The Last Decade

Zsuzsa Bagoly

63 papers receiving 1.6k citations

Peers

Countries citing papers authored by Zsuzsa Bagoly

Since Specialization

Citations

This map shows the geographic impact of Zsuzsa Bagoly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsuzsa Bagoly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsuzsa Bagoly more than expected).

Fields of papers citing papers by Zsuzsa Bagoly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zsuzsa Bagoly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsuzsa Bagoly. The network helps show where Zsuzsa Bagoly may publish in the future.

Co-authorship network of co-authors of Zsuzsa Bagoly

This figure shows the co-authorship network connecting the top 25 collaborators of Zsuzsa Bagoly. A scholar is included among the top collaborators of Zsuzsa Bagoly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zsuzsa Bagoly. Zsuzsa Bagoly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular disease and microbiome: focus on ischemic stroke 2025 ·Polskie Archiwum Medycyny Wewnętrznej ·István Szegedi, (unknown), (unknown), (unknown), Zsuzsa Bagoly	1
2	Elevated Blood Alcohol Concentration at Stroke Onset Predicts Poor Clinical Outcomes and Mortality After Intracerebral Hemorrhage: A Retrospective Cohort Study 2025 ·Neurology and Therapy ·(unknown), Attila Nagy, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Péter Juhász, (unknown), (unknown), Tünde Csépány, (unknown), Zsuzsa Bagoly, László Oláh	0
3	Hemorrhagic transformation after acute ischemic stroke thrombolysis treatment: navigating the landscape of hemostasis genetic risk factors 2024 ·Journal of Thrombosis and Haemostasis ·Zsuzsa Bagoly	4
4	Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype 2023 ·Thrombosis and Haemostasis ·Joanna Natorska, Javier Corral, María Eugenia de la Morena‐Barrio, Carlos Bravo‐Pérez, Zsuzsa Bagoly, Zsuzsanna Bereczky, Jacek Treliński, (unknown), (unknown), Anetta Undas, Michał Ząbczyk	8
5	Low α2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis 2022 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), István Szegedi, Ëva Katona, (unknown), (unknown), (unknown), (unknown), István Fekete, Klára Fekete, Ervin Berényi, László Oláh, László Csiba, Zsuzsa Bagoly	3
6	Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients 2021 ·Biomolecules ·Zsuzsa Bagoly, (unknown), (unknown), István Szegedi, (unknown), (unknown), László Csiba, Ëva Katona	9
7	Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis 2021 ·PLoS ONE ·István Szegedi, (unknown), Attila Nagy, (unknown), (unknown), (unknown), Levente Lánczi, Ervin Berényi, László Oláh, (unknown), László Csiba, Zsuzsa Bagoly	4
8	A Modified in vitro Clot Lysis Assay Predicts Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients—The IRONHEART Study 2021 ·Frontiers in Neurology ·(unknown), (unknown), István Fekete, Klára Fekete, (unknown), Judit Tóth, (unknown), László Csiba, Zsuzsa Bagoly	7
9	Prognostic Value of Various Hemostasis Parameters and Neurophysiological Examinations in Spontaneous Intracerebral Hemorrhage: The IRONHEART Study Protocol 2021 ·Frontiers in Neurology ·(unknown), (unknown), Zsuzsa Bagoly, (unknown), (unknown), (unknown), Judit Tóth, Klára Fekete, István Fekete, László Csiba	2
10	Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques 2020 ·Cardiology Research and Practice ·(unknown), Zsuzsa Bagoly, (unknown), (unknown), (unknown), (unknown), (unknown), Attila Nagy, Anna V. Oláh, László Nagy, Marcell Clemens, László Csiba, Zoltán Csanádi	6
11	The factor XIII‐A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations 2020 ·Journal of Thrombosis and Haemostasis ·Sravya Kattula, Zsuzsa Bagoly, (unknown), László Muszbek, Alisa S. Wolberg	11
12	A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids 2019 ·Journal of Immunological Methods ·(unknown), (unknown), Zsuzsa Bagoly, (unknown), Eszter Angéla Tóth, (unknown), Zsuzsanna Bereczky, László Muszbek, Ëva Katona	7
13	Inherited thrombophilia and the risk of myocardial infarction: current evidence and uncertainties 2019 ·Kardiologia Polska ·Zsuzsanna Bereczky, (unknown), Zsuzsa Bagoly	10
14	Sex-specific alteration to α2-antiplasmin incorporation in patients with type 2 diabetes 2019 ·Thrombosis Research ·Agata Hanna Bryk, Jakub Siudut, Elżbieta Broniatowska, Zsuzsa Bagoly, (unknown), Ëva Katona, Anetta Undas	9
15	Markers of Coagulation and Fibrinolysis Predicting the Outcome of Acute Ischemic Stroke Thrombolysis Treatment: A Review of the Literature 2019 ·Frontiers in Neurology ·Zsuzsa Bagoly, István Szegedi, (unknown), (unknown), László Csiba	41
16	Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation 2017 ·BioMed Research International ·(unknown), Zoltán Csanádi, (unknown), (unknown), (unknown), (unknown), (unknown), László Muszbek, Zsuzsanna Bereczky, László Csiba, Zsuzsa Bagoly	18
17	Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis 2012 ·Thrombosis Research ·Zsuzsa Koncz, Zsuzsa Bagoly, Gizella Haramura, (unknown), László Muszbek	7
18	Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation 2011 ·Thrombosis Research ·Zsuzsa Koncz, Zsuzsa Bagoly, Gizella Haramura, (unknown), László Muszbek	4
19	Factor XIII, clot structure, thrombosis 2011 ·Thrombosis Research ·Zsuzsa Bagoly, Zsuzsa Koncz, Jolán Hársfalvi, László Muszbek	101
20	The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma 2006 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Amir H. Shemirani, Gizella Haramura, Zsuzsa Bagoly, László Muszbek	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact